News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

May

6

electroCore Announces First Quarter 2021 Financial Results

Record first quarter 2021 net sales of $1.2 million, increased 64% over first quarter 2020...

5

electroCore, Inc. Announces Regulatory Approval in Canada

gammaCore Sapphire products approved for prevention and therapeutic treatment of migraine and cluster headache...

24

electroCore, Inc. Announces Publication of a Voluntary ex-ante Transparency Tender Notice Award by NHS England to Fund Continued Use of gammaCore™ in England

Reimbursement for gammaCore™ in England BASKING RIDGE, N.J., Aug. 24, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR),...

Recent developments

News

May

6

electroCore Announces First Quarter 2021 Financial Results

April

5

electroCore, Inc. Announces Regulatory Approval in Canada

August

24

electroCore, Inc. Announces Publication of a Voluntary ex-ante Transparency Tender Notice Award by NHS England to Fund Continued Use of gammaCore™ in England